Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.Financial_Report.xls
10-K - ANNUAL REPORT - DS HEALTHCARE GROUP, INC.dskx_10k.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R4.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R8.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R3.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R1.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R2.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R7.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R9.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R19.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R18.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R17.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R13.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R11.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R12.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R15.htm
EX-32.1 - CERTIFICATION - DS HEALTHCARE GROUP, INC.dskx_ex32z1.htm
EX-32.2 - CERTIFICATION - DS HEALTHCARE GROUP, INC.dskx_ex32z2.htm
EX-23.2 - CONSENT - DS HEALTHCARE GROUP, INC.dskx_ex23z2.htm
EX-31.2 - CERTIFICATION - DS HEALTHCARE GROUP, INC.dskx_ex31z2.htm
EX-23.1 - CONSENT - DS HEALTHCARE GROUP, INC.dskx_ex23z1.htm
EX-31.1 - CERTIFICATION - DS HEALTHCARE GROUP, INC.dskx_ex31z1.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R5.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R20.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R10.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R21.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R16.htm
XML - IDEA: XBRL DOCUMENT - DS HEALTHCARE GROUP, INC.R14.htm
v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Cash Flows from Operating Activities:    
Net Loss $ (980,892) $ (149,813)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 200,722 118,178
Bad debts/Product return and advertising reserve 153,684 [1],[2] 28,546
Stock/Warrants issued/vested for services 443,091 [3],[4],[5] 317,171 [6],[7],[8]
Changes in operating assets and liabilities:    
Accounts receivable (1,304,182) (77,015)
Inventory (993,105) (463,572)
Prepaid expenses and other current assets (5,644) (32,549)
Accounts payable and accrued expenses 417,003 (340,589)
Other current liabilities 56,270 7,768
Net cash used in operating activities (2,013,053) (591,875)
Cash Flows from Investing Activities:    
Purchase of furniture and equipment (50,945)   
Purchase brand identity and supplier exclusive agreement    (106,666)
Security deposits 2,305 (9,403)
Net cash used in investing activities (48,640) (116,069)
Cash Flows from Financing Activities:    
Proceeds from sale of stock 3,799,500 [10],[9] 844,500 [11],[12]
Less issuance costs (599,869) [13],[14] (249,600) [15],[16]
Net cash provided by financing activities 3,199,631 594,900
Increase (Decrease) in cash 1,137,938 (113,044)
Cash, Beginning of Year 146,405 259,449
Cash, End of Year 1,284,343 146,405
Supplemental Information:    
Cash paid for interest      
Cash paid for taxes      
Non-Cash Items:    
Issuance cost paid in warrants $ 24,670   
[1] Bad debts - $41,032
[2] Product return and advertising reserve - $112,652
[3] Stock issued for services - $116,847
[4] Warrants issued for financial services - $134,244
[5] Warrants vested for services - $192,000
[6] Stock issued for services - $21,500
[7] Warrants issued for financial services - $133,600
[8] Warrants vested for services - $162,071
[9] Proceeds from sale of stock under SPA - $1,730,000
[10] Proceeds from sale of stock to others - $2,069,500
[11] Proceeds from sale of stock to others - $844,500
[12] Proceeds from sale of stock under SPA - $0
[13] Issuance costs: sale of stock to others - $459,769
[14] Issuance costs: sale of stock under SPA - $140,000
[15] Issuance costs: sale of stock to others - $249,600
[16] Issuance costs: sale of stock under SPA - $0